stock-detail (EBS)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/20/2017 12:17 am

4/20/2017 12:17 am

4/20/2017 12:17 am

4/20/2017 12:17 am

Emergent BioSolutions Signs $53 Million Modification to BARDA Contract for the Manufacture of Botulism Antitoxin

3/31/2017 11:00 am

[GlobeNewswire] - GAITHERSBURG, Md., March 31, 2017-- Emergent BioSolutions Inc. today announced that it has signed a modification to its contract with the Biomedical Advanced Research and Development Authority to manufacture ...

Emergent BioSolutions Awarded $100 Million BARDA Contract for BioThrax Deliveries to the Strategic National Stockpile

3/17/2017 11:00 am

[GlobeNewswire] - GAITHERSBURG, Md., March 17, 2017-- Emergent BioSolutions Inc. today announced that it has signed a two-year contract with the Biomedical Advanced Research and Development Authority, a division within ...

Blog Coverage Galapagos Announced New Phase-II Studies Led by Filgotinib Collaboration Partner Gilead Sciences

3/13/2017 12:01 pm

[Accesswire] - Upcoming AWS Coverage on Emergent BioSolutions Post-Earnings Results LONDON, UK / ACCESSWIRE / March 13, 2017 / Active Wall St. blog coverage looks at the headline from Galapagos N.V. (NASDAQ: GLPG ) as ...